Trials / Completed
CompletedNCT00912431
Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers
A Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in the Cerebrospinal Fluid (CSF) of Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The objectives of this study are to determine the cerebrospinal fluid (CSF) levels of ABT-126 and to examine the effects of ABT-126 on exploratory biomarkers after administration of a single does of ABT-126 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-126 | ABT-126 administered on Day 1 of Period 1 |
| DRUG | Placebo | Placebo for ABT-126 administered on Day 1 of Period 2 |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-08-01
- First posted
- 2009-06-03
- Last updated
- 2010-11-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00912431. Inclusion in this directory is not an endorsement.